Home › Research › Long-term cohort studies
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
Chen J, Mooldijk SS, Licher S, Waqas K, Ikram MK, Uitterlinden AG, Zillikens MC, Ikram MA.. JAMA network open, 2021-01-04
Topic: Risk, prevention and care in population studies
Plain-language summary
Importance Advanced glycation end products (AGEs) and their receptor (RAGE) are implicated in the pathophysiological processes of dementia and potentially underlie the association of diabetes with neurodegeneration. However, longitudinal studies examining this association are lacking. Objective To determine whether markers of the AGE-RAGE system are associated with prevalent and incident dementia and with cognition.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 1,021 participants. In the Rotterdam Study, plasma markers of the advanced glycation end product and receptor system were measured and related to prevalent and incident dementia and cognition. Reported effect size: 56.2%; 55.2%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chen, J., Mooldijk, S. S., Licher, S., Waqas, K., Ikram, M. K., Uitterlinden, A. G., et al. (2021). Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2020.33012
Vancouver
Chen J, Mooldijk SS, Licher S, Waqas K, Ikram MK, Uitterlinden AG, et al. Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia. JAMA network open. 2021. doi:10.1001/jamanetworkopen.2020.33012. PMID: 33416887.
BibTeX
@article{chen2021-33416887,
author = {Chen, J. and Mooldijk, S. S. and Licher, S. and Waqas, K. and Ikram, M. K. and Uitterlinden, A. G. and Zillikens, M. C. and Ikram, M. A.},
title = {{Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia}},
journal = {JAMA network open},
year = {2021},
doi = {10.1001/jamanetworkopen.2020.33012},
pmid = {33416887},
url = {https://doi.org/10.1001/jamanetworkopen.2020.33012}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- However, longitudinal studies examining this association are lacking.
- Objective To determine whether markers of the AGE-RAGE system are associated with prevalent and incident dementia and with cognition.
- Design, setting, and participants In this population-based cohort study including participants from the prospective Rotterdam Study, extracellular newly identified RAGE binding protein (EN-RAGE) and soluble RAGE (S-RAGE) were measured in plasma collected between 1997 and 1999 in a random selection of participants, and additionally in participants with prevalent dementia.
- Participants without dementia were followed up for dementia until 2016.
Why it matters
In the Rotterdam Study, plasma markers of the advanced glycation end product and receptor system were measured and related to prevalent and incident dementia and cognition. It examines possible biological markers and does not test any treatment, cure, or prevention.
Study details
- Study designcohort study
- Participants1,021
- Effect size56.2%; 55.2%
- Evidence strengthModerate
How this study scored 64/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA network open) |
| Journal's citation record | 2 / 4 | JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,021 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 66 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.4 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 3 / 6 | Cited 6.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 40 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author M. Arfan Ikram: h-index 167 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33416887) |
| Free to read | 2 / 2 | Free to read |
| Total | 64 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamanetworkopen.2020.33012
- PubMed: 33416887
- Original source →
- Free full text: JAMA Network Open →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.